≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Collapsed vertebra, not elsewhere classified

DOID EFO Endpoint Browser PheWeb

M13_VERTEBCOLLAPSE

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — M48.5
  • Cause of death: ICD-10 — M48.5

2 out of 7 registries used, show all original rules.

271

4. Check minimum number of events

None

271

5. Include endpoints

None

271

6. Filter based on genotype QC (FinnGen only)

271

Control definitions (FinnGen only)

Control exclude
M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
M48
Name in latin
Vertebra collapsa non alibi classificata

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2977 1951 1011
Only index persons 2606 1732 874
Unadjusted period prevalence (%)
Whole population 0.05 0.06 0.03
Only index persons 0.05 0.06 0.03
Median age at first event (years)
Whole population 76.32 78.64 71.80
Only index persons 76.04 78.45 71.27

-FinnGen-

Key figures

All Female Male
Number of individuals 271 178 93
Unadjusted period prevalence (%) 0.05 0.06 0.04
Median age at first event (years) 73.22 74.06 71.60

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
243
Matched controls
2428
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M48.5
ICD-10 Finland
Collapsed vertebra, not elsewhere classified
+∞
323.0
243
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
24.9
48.1
69
38
M54.5
ICD-10 Finland
Low back pain
8.1
43.2
118
252
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
8.7
39.6
98
175
M48.0
ICD-10 Finland
Spinal stenosis
36.0
36.8
47
16
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
39.8
34.5
43
13
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
13.9
33.6
60
56
N02AX02
ATC
tramadol; systemic, rectal
5.3
32.5
145
530
M54.9
ICD-10 Finland
Dorsalgia, unspecified
14.8
30.8
53
45
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
43.3
30.3
37
10
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
19.3
30.0
46
29
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
24.9
28.5
40
19
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
27.0
28.5
39
17
N03AX16
ATC
pregabalin; oral
6.1
27.8
88
207
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.5
27.2
152
656
N03AX12
ATC
gabapentin; oral
8.8
26.8
61
89
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
32.7
26.2
34
12
N02AA05
ATC
oxycodone; systemic
5.5
25.9
90
234
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
120.4
20.9
22
*
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
216.9
19.9
20
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
19.9
150
754
M81.9
ICD-10 Finland
Osteoporosis, unspecified
8.9
19.7
43
57
M54.4
ICD-10 Finland
Lumbago with sciatica
8.3
19.2
44
63
M05BA04
ATC
alendronic acid; oral
5.1
19.1
67
169
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.8
18.8
103
396
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
14.6
18.5
31
24
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
8.9
18.0
39
51
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
45.8
17.6
21
5
M54.6
ICD-10 Finland
Pain in thoracic spine
14.9
17.0
28
21
L03
ICPC
Low back symptom/complaint
4.1
16.9
75
237
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.2
16.5
126
608
318
Kela drug reimbursment
Teriparatide
64.5
16.0
18
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.1
15.7
121
584
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
34.2
15.0
19
6
M05BX04
ATC
denosumab; parenteral
6.2
14.4
40
75
H05AA02
ATC
teriparatide; parenteral
79.7
13.7
15
*
A02BC02
ATC
pantoprazole; systemic
3.0
13.7
176
1140
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
6.4
13.5
36
64
N02BE01
ATC
paracetamol; systemic, rectal
4.5
13.5
223
1726
M03BX02
ATC
tizanidine; oral
2.8
13.4
139
781
N02AJ06
ATC
codeine and paracetamol; systemic
3.0
12.4
91
409
C90.0
ICD-10 Finland
Multiple myeloma
19.3
12.2
18
10
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.1
11.8
74
297
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
20.2
11.8
17
9
L95
ICPC
Osteoporosis
6.9
11.6
29
47
C03CA01
ATC
furosemide; systemic
2.6
11.6
129
735
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.8
11.6
97
468
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
26.5
11.3
15
6
X59
ICD-10 Finland
Exposure to unspecified factor
3.3
11.3
62
226
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.3
10.9
60
218
R53
ICD-10 Finland
Malaise and fatigue
3.0
10.8
73
306
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.7
10.8
95
469
C07AB07
ATC
bisoprolol; oral
2.5
10.7
157
1023
153
Kela drug reimbursment
Lenalidomid
62.8
10.7
12
*
L04AX04
ATC
lenalidomide; oral
62.8
10.7
12
*
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
+∞
10.5
10
*
N06AX21
ATC
duloxetine; oral
5.3
10.2
31
65
Z01.8
ICD-10 Finland
Other specified special examinations
3.0
10.2
66
267
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.0
10.1
42
121
M79.6
ICD-10 Finland
Pain in limb
2.6
10.0
91
453
UJF32
NOMESCO Finland
Coloscopy
2.7
9.9
80
371
B01AB05
ATC
enoxaparin; parenteral
2.5
9.9
98
513
M01AH05
ATC
etoricoxib; oral
2.4
9.7
127
764
N06AX11
ATC
mirtazapine; oral
2.6
9.5
90
453
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
4.6
9.5
33
80
A02BC05
ATC
esomeprazole; systemic
2.4
9.5
109
613
M43.1
ICD-10 Finland
Spondylolisthesis
31.4
9.5
12
*
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
103.9
9.5
10
*
M54
ICD-10 Finland
Dorsalgia
4.3
9.4
35
91
A02BC01
ATC
omeprazole; systemic
2.5
9.4
93
483
R07.4
ICD-10 Finland
Chest pain, unspecified
2.6
9.3
87
434
NE1AA
NOMESCO Finland
Pelvis X-ray examination
4.5
9.3
33
82
L02
ICPC
Back symptom/complaint
4.5
9.1
32
79
X58
ICD-10 Finland
Exposure to other specified factors
3.8
9.0
39
117
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.4
9.0
45
152
R52.2
ICD-10 Finland
Other chronic pain
9.2
9.0
18
21
A02BA02
ATC
ranitidine; systemic
2.7
8.9
71
325
M01AH02
ATC
rofecoxib; oral
3.1
8.8
52
194
A02BC03
ATC
lansoprazole; oral
2.5
8.8
88
453
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.8
8.6
62
267
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
5.0
8.6
27
59
M51.8
ICD-10 Finland
Other specified intervertebral disc disorders
93.2
8.5
9
*
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
+∞
8.4
8
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.9
8.4
55
224
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
2.4
8.3
89
477
XW000
NOMESCO Finland
Bone marrow biopsy
6.3
8.2
21
36
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
13.6
8.0
13
10
A04AA01
ATC
ondansetron; systemic, rectal
4.5
7.9
27
65
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
11.3
7.9
14
13
L28
ICPC
Limited function/disability (L)
2.7
7.8
60
267
D64.9
ICD-10 Finland
Anaemia, unspecified
3.2
7.8
43
154
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
3.8
7.7
32
93
J01DB01
ATC
cefalexin; oral
2.3
7.5
191
1482
Z46.9
ICD-10 Finland
Fitting and adjustment of unspecified device
13.9
7.5
12
9
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
82.5
7.5
8
*
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
82.5
7.5
8
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
3.5
7.3
34
108
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.3
7.3
36
120
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.4
7.3
21
42
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.2
7.3
40
142
M03BC01
ATC
orphenadrine (citrate); systemic
3.0
7.3
44
166
M47.82
ICD-10 Finland
Other spondylosis, cervical region
16.4
7.3
11
7
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.2
7.3
94
539
H02AB06
ATC
prednisolone; systemic
2.1
7.2
119
759
A28
ICPC
Limited function/disability NOS
2.5
7.2
63
299
A06AD11
ATC
lactulose; oral
2.5
7.2
63
300
R52.9
ICD-10 Finland
Pain, unspecified
3.8
7.0
29
84
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
14.3
7.0
11
8
L86
ICPC
Back syndrome with radiating pain
6.4
6.9
17
28
N05BA04
ATC
oxazepam; oral
2.3
6.9
73
380
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.7
6.8
51
220
M80.5
ICD-10 Finland
Idiopathic osteoporosis with pathological fracture
41.2
6.8
8
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.3
6.7
19
38
AA1AD
NOMESCO Finland
CT of head and brain
2.2
6.6
79
437
NA1AD
NOMESCO Finland
Cervical spine CT examination
6.0
6.6
17
30
S22.3
ICD-10 Finland
Fracture of rib
3.8
6.6
27
78
D07AC01
ATC
betamethasone; topical
2.1
6.5
89
520
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.2
6.5
78
433
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
71.7
6.5
7
*
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
71.7
6.5
7
*
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
+∞
6.3
6
*
N30.0
ICD-10 Finland
Acute cystitis
2.6
6.2
48
212
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.9
6.2
24
66
N03AE01
ATC
clonazepam; systemic
4.4
6.2
21
51
G04CA02
ATC
tamsulosin; oral
2.4
6.2
57
277
ZX120
NOMESCO Finland
Intravenous
3.1
6.1
32
112
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.6
6.1
45
195
M05BA07
ATC
risedronic acid; oral
4.3
6.1
21
52
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.7
6.0
25
73
M54.8
ICD-10 Finland
Other dorsalgia
7.6
6.0
13
18

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(21494890) Protein electrophoresis panel - 24 hour Urine
21
23
9.81
17.55
4.8
2.7
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
35
72
5.43
16.66
16.1
3.7
mg/l
62.3
69.9
0.05
27
56
(3034860) Kappa light chains.free [Mass/volume] in Serum
35
72
5.43
16.66
15.9
3.7
mg/l
84.8
87.0
0.02
27
56
(36304419) Bacteria [Presence] in Urine
118
568
2.91
16.15
5.0
3.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
15
11
14.38
16.04
2.3
1.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
121
593
2.88
15.98
5.1
3.1
e6/l
0.3
0.5
0.67
98
457
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
182
1105
2.97
15.97
13.9
5.9
mmol/l
1.2
1.2
0.91
152
902
(40760888) Immunoglobulin light chains.free panel - Serum
29
52
6.13
15.92
11.9
4.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
27
46
6.41
15.58
3.2
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
55
172
3.76
15.38
10.0
2.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
141
766
2.75
15.04
6.8
3.6
e6/l
172.3
127.2
0.18
104
557
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
150
843
2.75
14.93
3.1
2.2
nmol/l
80.4
78.6
0.31
136
711
(42870588) Differential panel, method unspecified - Blood
126
653
2.74
14.66
9.8
5.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
120
607
2.75
14.64
7.9
3.9
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
75
298
3.10
14.26
3.6
2.3
%
20.2
21.0
0.17
66
248
(3022948) Iron [Moles/volume] in Serum or Plasma
81
337
3.00
14.20
3.7
2.3
umol/l
11.2
12.0
0.40
74
298
(3004789) Transferrin [Mass/volume] in Serum or Plasma
78
318
3.04
14.17
3.5
2.3
g/l
2.2
2.3
0.82
72
282
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
171
1046
2.72
14.07
9.5
5.9
umol/l
10.8
12.5
1.29
157
980
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
112
559
2.71
13.88
2.8
2.2
mg/l
3.2
3.3
0.07
89
464
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
139
773
2.64
13.82
5.8
3.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
84
367
2.87
13.38
2.5
1.8
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
44
132
3.79
12.98
5.6
3.2
g/l
10.4
10.6
0.04
37
122
(3002582) Erythrocytes [#/volume] in Urine
124
671
2.56
12.80
5.7
3.1
e6/l
29.7
150.3
0.69
98
527
(3024561) Albumin [Mass/volume] in Serum or Plasma
157
953
2.54
12.63
7.1
3.9
g/l
33.4
34.8
1.79
138
861
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
160
991
2.50
12.16
14.7
5.2
mmol/l
1.2
1.2
1.34
150
865
(3035350) Ketones [Presence] in Urine by Test strip
159
983
2.49
12.11
6.1
4.0
estimate
0.0
0.0
0.00
28
182
(3026782) Osmolality of Urine
95
463
2.62
12.06
4.2
2.8
mosm/kgh2o
514.9
551.2
0.97
83
394
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
64
256
2.96
11.85
2.2
1.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
134
776
2.44
11.67
3.8
3.2
ng/l
2327.5
2008.1
0.21
113
657
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
111
591
2.49
11.62
3.3
2.3
u/l
49.7
58.2
2.41
98
533
(3032080) INR in Blood by Coagulation assay
152
934
2.43
11.55
16.2
9.7
inr
1.2
1.4
0.94
40
275
(3015377) Calcium [Moles/volume] in Serum or Plasma
131
755
2.42
11.48
4.4
3.0
mmol/l
2.3
2.4
2.91
118
644
(3001122) Ferritin [Mass/volume] in Serum or Plasma
135
790
2.41
11.41
4.2
2.6
ug/l
136.7
132.0
0.10
118
698
(3037467) Urinalysis macro (dipstick) panel - Urine
202
1422
2.65
11.26
6.4
4.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
67
283
2.82
11.17
3.0
2.6
%
1.8
1.8
0.01
59
248
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
73
324
2.72
11.06
5.3
3.0
e6/l
4.7
3.0
0.39
39
182
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
63
259
2.87
11.04
2.2
1.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
53
200
3.05
10.81
5.4
2.1
umol/l
7.2
10.5
0.92
44
173
(3009261) Glucose [Presence] in Urine by Test strip
157
999
2.36
10.75
6.6
4.2
estimate
0.0
0.0
0.00
28
177
(3023520) Reticulocytes [#/volume] in Blood
54
207
3.01
10.71
2.8
2.8
e9/l
62.7
69.8
0.83
34
159
(3021601) Nitrite [Presence] in Urine by Test strip
157
1000
2.36
10.71
9.4
5.8
estimate
0.0
0.0
0.00
28
176
(3018418) pH of Serum or Plasma
119
674
2.36
10.66
10.4
3.6
ph
7.4
7.4
0.78
22
119
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
213
1559
2.71
10.59
14.8
6.8
u/l
81.6
80.8
0.09
200
1416
(3001604) Monocytes [#/volume] in Blood
150
940
2.33
10.59
11.2
5.0
e9/l
0.6
0.6
1.01
122
806
(3013115) Eosinophils [#/volume] in Blood
154
977
2.33
10.55
11.4
5.2
e9/l
0.2
0.2
0.04
129
848
(3019198) Lymphocytes [#/volume] in Blood
152
962
2.32
10.43
11.5
5.1
e9/l
1.6
1.8
1.69
127
840
(3028026) IgM [Mass/volume] in Serum or Plasma
36
109
3.66
10.42
3.2
2.1
g/l
0.8
2.0
1.29
31
99
(3006315) Basophils [#/volume] in Blood
150
947
2.31
10.31
11.2
5.0
e9/l
0.0
0.0
0.71
122
813
(3018010) Neutrophils/100 leukocytes in Blood
146
915
2.29
10.17
11.7
5.3
%
61.2
58.6
1.63
135
856
(3007853) Bacteria identified in Skin by Aerobe culture
55
222
2.85
9.90
1.9
1.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
72
334
2.57
9.88
4.3
2.8
e6/l
1.1
1.4
0.39
39
190
(3013650) Neutrophils [#/volume] in Blood by Automated count
167
1116
2.29
9.85
18.0
8.7
e9/l
4.5
4.2
0.69
143
973
(3022096) Basophils/100 leukocytes in Blood
141
879
2.26
9.85
11.2
5.3
%
0.7
0.7
0.71
132
813
(3026008) Bacteria identified in Urine by Culture
131
795
2.25
9.74
5.2
3.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
143
900
2.25
9.72
11.9
5.2
%
2.9
2.7
0.51
133
836
(3019069) Monocytes/100 leukocytes in Blood
143
905
2.23
9.53
12.9
5.6
%
9.8
8.9
1.95
134
843
(3002030) Lymphocytes/100 leukocytes in Blood
145
924
2.22
9.49
12.2
5.6
%
23.0
26.3
3.23
135
853
(3007164) IgA [Mass/volume] in Serum or Plasma
69
320
2.55
9.44
2.5
1.8
g/l
3.1
2.6
0.23
40
178
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
45
168
3.01
9.30
2.3
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
32
97
3.61
9.22
1.7
1.7
ug/l
0.3
5.5
1.01
24
81
(3000850) Epithelial cells [#/volume] in Urine
89
474
2.31
8.91
3.7
2.5
e6/l
4.8
5.8
0.58
83
420
(3003396) Base excess in Arterial blood by calculation
57
248
2.64
8.84
10.1
5.9
mmol/l
1.6
1.6
0.01
50
198
(3042936) Bacteria identified in Isolate by Culture
63
288
2.55
8.83
2.2
1.9
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
73
359
2.41
8.74
1.3
1.2
u/ml
1.6
1.1
0.26
18
82
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
27
77
3.78
8.49
4.1
2.1
u/ml
0.4
0.4
0.04
17
45
(3013707) Erythrocyte sedimentation rate by Westergren method
197
1461
2.28
8.36
6.1
3.9
mm/h
19.8
15.2
1.96
180
1296
(3045142) Bone marrow Pathology biopsy report
13
20
6.78
8.14
1.2
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
172
1219
2.13
8.06
10.5
4.4
mmol/l
6.9
6.8
0.24
162
1129
(3036481) Cortisol [Moles/volume] in Serum or Plasma
42
165
2.83
7.88
1.8
2.1
nmol/l
330.9
400.1
0.94
36
147
(3042111) Morphology [Interpretation] in Bone marrow Narrative
18
40
4.75
7.77
1.6
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
97
561
2.14
7.76
4.4
2.7
u/l
34.7
32.6
0.13
87
541
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
103
3.27
7.75
14.0
1.7
g/l
3.5
3.6
0.10
25
73
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
104
3.24
7.63
14.0
1.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
104
3.24
7.63
14.0
1.7
g/l
7.3
7.6
0.39
26
76
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
106
639
2.08
7.56
2.7
1.9
u/l
251.7
202.2
0.16
95
593
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
31
106
3.17
7.40
3.0
3.9
mmol/l
1.4
2.5
0.64
22
86
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
133
881
2.00
7.23
6.3
3.8
ng/l
50.5
81.0
0.36
109
668
(3019309) Folate [Moles/volume] in Red Blood Cells
88
504
2.10
7.13
2.3
1.8
nmol/l
1107.4
1084.5
0.08
64
367
(3011397) Hemoglobin [Presence] in Urine by Test strip
81
450
2.14
7.09
5.7
4.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
157
1111
1.98
6.97
4.4
2.8
u/l
65.9
51.7
1.05
141
994
(3017817) Protein [Mass] in Urine collected for unspecified duration
12
20
6.23
6.96
2.7
3.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
139
947
1.96
6.85
2.6
2.1
pmol/l
91.8
94.8
0.24
74
454
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
43
185
2.57
6.75
2.6
2.0
u/l
32.9
29.4
0.37
36
154
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
39
161
2.66
6.64
2.1
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
40
168
2.62
6.58
14.2
7.0
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
24
77
3.32
6.34
17.2
1.9
g/l
0.0
0.0
0.00
24
66
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
132
903
1.90
6.26
2.6
2.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
41
179
2.52
6.23
4.0
3.2
ng/l
78.8
82.2
0.11
31
147
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
131
895
1.90
6.22
5.5
3.8
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
24
78
3.28
6.21
17.2
1.9
g/l
0.0
0.0
0.00
24
66
(3021879) Hepatitis B virus core Ab [Presence] in Serum
28
100
3.01
6.21
1.6
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
77
446
2.01
5.91
5.7
3.5
ng/l
168.1
258.6
0.39
68
378
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
19
55
3.64
5.84
1.6
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
47
225
2.32
5.84
1.4
1.3
titre
413.3
401.6
—
6
49
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
27
98
2.95
5.82
8.5
7.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
28
105
2.86
5.70
2.2
1.8
%
1.4
1.6
0.81
22
90
(3044640) Blood type and Crossmatch panel - Blood
101
650
1.88
5.65
4.0
2.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
14
33
4.42
5.63
1.9
2.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
34
143
2.58
5.57
4.7
3.6
%
0.0
0.2
1.43
13
42
(21494434) Karyotype in Bone marrow
11
21
5.42
5.57
1.0
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
91
569
1.90
5.54
2.1
1.5
nmol/l
20.0
21.0
0.26
79
461
(3025159) Blasts/100 leukocytes in Blood
33
138
2.58
5.47
4.3
3.7
%
0.0
2.8
0.55
12
34
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
81
490
1.93
5.43
3.6
2.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
17
48
3.71
5.42
1.3
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
17
48
3.71
5.42
1.3
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
32
133
2.59
5.37
2.2
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
15
39
4.01
5.34
1.5
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
35
155
2.44
5.15
4.6
3.6
%
0.2
0.8
2.11
13
47
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
230
1951
2.18
5.15
39.2
15.3
mg/l
25.8
25.5
0.05
211
1589
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
19
60
3.33
5.15
1.3
1.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
51
266
2.13
5.13
1.3
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
31
131
2.54
5.03
4.5
3.8
%
0.4
0.4
0.05
11
32
(3012501) Base excess in Blood by calculation
15
42
3.72
4.84
3.2
2.1
mmol/l
2.9
2.3
—
10
26
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
15
43
3.63
4.68
1.9
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
54
299
2.01
4.62
1.3
1.2
iu/ml
25.9
39.4
0.66
19
102
(3022806) Fractional oxyhemoglobin in Capillary blood
10
21
4.91
4.57
1.8
2.1
%
87.1
88.4
—
10
21
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
41
210
2.12
4.30
2.3
2.3
ug/l
5.8
6.5
0.14
31
176
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
16
51
3.27
4.28
1.9
1.8
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
18
62
3.04
4.26
4.9
3.9
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
72
451
1.81
4.22
4.9
2.9
mmol/l
2.5
2.5
0.04
67
398
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
16
52
3.21
4.15
1.8
1.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
23
4.48
4.12
1.6
1.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
13
37
3.64
4.10
3.2
2.3
%
15.4
16.1
—
5
20
(3041096) Erythrocytes [Presence] in Urine by Automated
84
555
1.74
4.10
6.3
4.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
48
266
1.98
4.08
1.2
1.2
u/ml
52.6
17.6
0.48
11
88
(3002032) Base excess in Venous blood by calculation
40
208
2.08
4.04
7.3
3.1
mmol/l
3.5
2.1
1.83
35
165
(3021589) Normoblasts [#/volume] in Blood
119
868
1.66
4.01
22.2
9.1
e9/l
0.0
0.0
0.43
89
723
(3027456) Digoxin [Moles/volume] in Serum or Plasma
20
76
2.76
3.99
3.8
3.2
nmol/l
0.8
0.8
0.10
14
58
(3009445) Proteinase 3 Ab [Units/volume] in Serum
21
83
2.66
3.90
1.3
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
109
783
1.66
3.86
7.7
4.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
29
3.91
3.84
1.3
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
29
3.91
3.84
1.5
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
11
29
3.91
3.84
1.5
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
34
3.65
3.81
1.4
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
203
1713
1.74
3.78
41.9
17.4
%
36.5
38.0
1.01
125
1076
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
5
12.23
3.78
1.2
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
29
137
2.25
3.71
5.3
4.0
—
—
—
0
0
(3017704) Immunofixation for Urine
9
16
5.78
3.69
2.9
1.8
—
—
—
0
0
(3012544) pH of Venous blood
40
216
2.00
3.65
7.4
3.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
24
105
2.41
3.64
1.7
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
108
788
1.62
3.53
2.2
2.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
8
13
6.30
3.52
1.4
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
33
168
2.10
3.52
1.8
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
27
127
2.25
3.49
1.1
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
21
88
2.50
3.49
3.0
3.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
41
227
1.95
3.49
1.5
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
74
492
1.69
3.47
16.5
6.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
32
3.54
3.37
1.5
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
22
96
2.41
3.37
1.2
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
15
54
2.88
3.31
1.4
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
18
72
2.61
3.28
2.1
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
28
3.67
3.22
1.6
1.7
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
47
280
1.82
3.20
13.8
5.7
mmol/l
102.1
104.6
1.82
47
269
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
11
6.50
3.20
1.7
1.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
11
6.50
3.20
1.3
1.6
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
9
20
4.62
3.14
2.1
1.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
23
106
2.28
3.13
2.7
2.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
64
422
1.68
3.06
2.2
1.7
mg/l
1.5
1.5
0.02
54
336
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
12
5.96
3.04
2.6
3.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
7
12
5.96
3.04
1.7
1.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
29
149
2.06
3.03
1.9
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
21
4.39
3.02
1.3
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
12
40
3.09
3.01
4.2
2.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
34
186
1.95
3.00
1.6
1.9
ug/g
337.4
137.2
1.29
23
142
(3020961) Endomysium IgA Ab [Titer] in Serum
17
70
2.52
2.94
1.4
1.1
titre
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
8
17
4.81
2.94
2.1
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
67
452
1.64
2.93
7.0
4.4
kg/l
1.0
1.0
0.83
21
76
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
16
64
2.59
2.93
1.5
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
72
496
1.62
2.90
4.9
3.0
umol/l
7570.0
8615.5
0.05
63
422
(3014765) Yersinia sp identified in Stool by Organism specific culture
16
65
2.55
2.84
1.5
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
14
53
2.73
2.84
1.6
1.4
ug/g
246.2
309.9
—
9
30
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
9
23
4.01
2.80
1.3
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
9
23
4.01
2.80
1.3
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
16
66
2.51
2.76
1.5
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
18
79
2.37
2.74
2.6
2.6
g/l
0.2
0.2
—
5
25
(3011648) Oxygen content in Venous blood
6
10
6.11
2.71
1.2
1.8
%
13.3
11.0
—
6
10
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
231
2082
1.74
2.70
20.0
10.2
u/l
21.8
23.2
0.87
218
1975
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
19
4.30
2.70
1.1
1.0
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
8
19
4.30
2.70
1.3
1.1
—
97.2
—
0
5
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
17
74
2.38
2.64
2.1
3.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
15
4.76
2.61
1.7
1.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
231
2087
1.72
2.61
43.8
18.4
mmol/l
138.7
139.6
4.23
221
2015
(3023103) Potassium [Moles/volume] in Serum or Plasma
231
2088
1.72
2.59
45.0
18.5
mmol/l
4.0
4.0
0.09
221
2013
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
73
517
1.56
2.59
1.9
1.8
pmol/l
416.0
439.9
0.24
57
401
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
39
235
1.77
2.56
6.1
3.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
21
102
2.15
2.55
7.7
2.7
e9/l
3.6
4.1
0.45
13
72
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
21
102
2.15
2.55
7.5
3.3
mmol/l
26.2
24.1
2.39
21
96
(3000330) Specific gravity of Urine by Test strip
25
131
2.00
2.50
4.7
4.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
16
4.46
2.49
1.1
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
12
45
2.74
2.48
1.1
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
9
27
3.41
2.41
4.9
1.8
%
76.3
60.4
—
9
27
(3006270) Folate [Moles/volume] in Blood
9
27
3.41
2.41
1.1
1.2
nmol/l
347.2
338.9
—
9
22
(3011288) Drugs identified in Urine by Screen method
6
12
5.09
2.41
1.8
2.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
22
3.71
2.38
3.3
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
8
6.34
2.38
1.0
1.0
—
—
—
0
0
(3013512) EKG study
89
670
1.49
2.36
6.2
4.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
223
2013
1.61
2.33
31.2
15.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
10
35
2.93
2.33
1.3
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
35
2.93
2.33
1.4
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
34
204
1.76
2.28
1.8
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
65
463
1.53
2.23
1.5
1.3
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
9
5.64
2.22
2.6
1.3
u/l
197.0
214.8
—
5
9
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
9
5.64
2.22
1.4
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
9
5.64
2.22
1.2
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
24
3.40
2.19
2.0
2.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
24
3.40
2.19
1.6
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
24
3.40
2.19
3.4
3.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
43
2.62
2.12
2.5
2.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
11
43
2.62
2.12
4.2
2.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
25
3.26
2.11
1.4
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
55
382
1.55
2.11
7.1
4.3
—
—
—
0
0
(3024731) MCV [Entitic volume]
234
2151
1.64
2.10
53.2
22.7
fl
92.7
91.4
3.36
225
2102
(3010503) CD19 cells [#/volume] in Blood
5
10
5.07
2.08
3.2
1.4
e9/l
0.1
0.1
—
5
10
(3010813) Leukocytes [#/volume] in Blood
234
2153
1.64
2.07
53.4
22.8
e9/l
7.0
6.8
0.85
223
2065
(3035941) MCH [Entitic mass]
234
2153
1.64
2.07
53.1
22.6
pg
30.6
30.2
1.39
225
2103
(3026361) Erythrocytes [#/volume] in Blood
234
2153
1.64
2.07
53.3
22.7
e12/l
4.2
4.4
5.74
223
2068
(3000963) Hemoglobin [Mass/volume] in Blood
234
2153
1.64
2.07
53.9
22.9
g/l
126.0
131.3
5.55
227
2103
(3004716) Salmonella sp identified in Stool by Organism specific culture
17
83
2.12
2.06
1.5
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
8
26
3.14
2.03
1.6
2.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
27
3.02
1.95
3.3
3.4
%
59.6
55.4
—
8
27
(3005570) Glucose [Moles/volume] in Urine
8
27
3.02
1.95
2.4
2.1
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
6
16
3.81
1.94
1.2
1.8
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
16
3.81
1.94
2.0
1.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
206
1856
1.46
1.89
34.1
15.3
ml/min/173m2
72.5
71.9
0.14
179
1517
(3007461) Platelets [#/volume] in Blood
233
2153
1.59
1.89
53.0
22.7
e9/l
245.4
243.4
0.16
222
2081
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
171
1494
1.39
1.85
5.1
3.9
pmol/l
15.6
15.2
0.98
158
1290
(4062490)
5
12
4.22
1.83
1.4
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
24
2.97
1.73
3.9
4.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
24
2.97
1.73
2.0
2.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
19
3.20
1.67
1.2
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
15
77
2.00
1.62
2.1
2.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
14
3.62
1.62
4.0
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
14
3.62
1.62
1.2
1.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
14
3.62
1.62
1.2
1.9
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
8
32
2.54
1.61
1.5
1.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
31
201
1.61
1.60
3.2
1.8
g/l
0.2
0.2
0.11
25
190
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
26
2.74
1.59
3.4
2.8
e9/l
3.7
3.6
—
7
26
(3014271) Vancomycin [Susceptibility]
6
20
3.04
1.59
4.5
2.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
203
1850
1.39
1.54
7.0
6.2
mmol/mol
42.1
40.9
0.71
185
1664
(1761482) Bacteria [#/volume] in Urine by Culture
16
86
1.91
1.54
6.5
5.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
11
51
2.21
1.52
1.3
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
27
2.63
1.52
2.6
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
27
2.63
1.52
1.6
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
27
2.63
1.52
2.6
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
27
2.63
1.52
2.6
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
27
2.63
1.52
2.6
1.4
—
—
—
0
0
(44806118)
6
21
2.90
1.51
1.0
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
6
21
2.90
1.51
1.3
1.5
—
—
—
0
0
(44790049)
6
21
2.90
1.51
1.0
1.5
—
—
—
0
0
(44790048)
6
21
2.90
1.51
1.0
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
6
21
2.90
1.51
1.3
1.5
—
—
—
0
0
(44790047)
6
21
2.90
1.51
1.0
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
28
2.54
1.46
2.6
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
22
2.76
1.44
1.3
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
9
41
2.24
1.38
3.7
2.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
23
2.64
1.37
1.3
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
23
2.64
1.37
1.3
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
30
201
1.55
1.37
1.4
1.4
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
5
17
2.98
1.36
1.2
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
161
1431
1.31
1.36
5.4
4.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
198
1813
1.34
1.34
6.1
4.8
mu/l
1.9
2.1
0.95
184
1570
(4281824)
6
24
2.53
1.31
1.2
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
8
34
2.39
1.30
1.4
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
211
1956
1.36
1.27
5.0
5.1
mmol/l
2.4
2.6
1.85
185
1732
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
64
504
1.35
1.27
5.7
5.2
ug/l
3.9
2.6
0.59
54
439
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
25
2.43
1.25
1.2
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
203
1874
1.33
1.24
4.4
4.5
mmol/l
1.5
1.5
0.41
176
1647
(3048929) Epstein Barr virus Ab [Presence] in Serum
8
37
2.20
1.22
1.4
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
69
553
1.33
1.22
7.5
4.2
estimate
0.0
0.0
0.00
28
174
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
21
134
1.61
1.18
2.1
3.4
ml/min/173m2
58.7
53.1
—
9
66
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
20
2.53
1.15
1.4
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
25
168
1.54
1.14
7.5
3.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
15
88
1.75
1.14
3.1
2.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
7
30
2.37
1.13
1.1
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
40
2.03
1.13
1.0
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
16
96
1.71
1.13
3.1
1.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
204
1895
1.31
1.12
4.4
4.5
mmol/l
4.3
4.5
1.55
179
1683
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
196
1816
1.29
1.06
4.0
4.0
mmol/l
1.3
1.3
0.43
164
1578
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
38
287
1.38
0.98
3.1
3.0
ug/l
0.7
0.9
0.40
26
201
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
23
2.20
0.98
2.4
2.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
23
2.20
0.98
2.4
2.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
23
2.20
0.98
2.4
2.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
23
2.20
0.98
1.4
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
27
2.25
0.94
2.8
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
14
86
1.66
0.93
2.4
1.6
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
16
102
1.60
0.92
1.3
1.3
—
58.8
—
0
5
(3014051) Protein [Presence] in Urine by Test strip
8
42
1.93
0.89
2.1
2.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
44
1.84
0.86
2.5
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
80
1.66
0.86
1.1
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
25
180
1.43
0.85
8.0
3.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
45
1.80
0.85
1.0
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
31
1.96
0.85
2.0
1.2
—
—
—
0
0
(4010399)
18
122
1.51
0.82
1.7
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
11
67
1.67
0.76
1.3
1.5
—
—
—
0
0
(3000492) Spirometry study
19
133
1.46
0.76
1.2
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
49
402
1.27
0.74
4.3
4.4
%
21.3
21.6
0.04
23
206
(4035726)
26
195
1.37
0.72
1.4
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
50
596
0.80
0.69
3.5
3.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
29
224
1.33
0.68
1.3
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
29
1.74
0.64
1.0
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
203
1932
1.20
0.63
5.2
4.9
mmol/l
6.1
6.1
0.02
181
1686
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
8
49
1.65
0.62
1.1
1.1
—
17.0
—
0
5
(3045788) Cell count panel - Pleural fluid
5
30
1.68
0.61
1.4
1.3
—
—
—
0
0
(3019225) pH of Specimen
28
220
1.30
0.60
10.0
4.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
6
35
1.73
0.58
2.2
2.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
60
689
0.83
0.58
4.0
3.8
mg/mmol
9.2
8.1
0.11
41
428
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
33
267
1.27
0.57
16.8
7.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
36
1.68
0.57
1.3
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
55
1.47
0.56
1.8
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
38
1.59
0.54
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
61
1.49
0.54
1.3
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
13
93
1.42
0.49
1.2
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
5
37
1.36
0.37
2.6
1.2
nmol/l
1.1
0.9
—
5
29
(3002256) Pathology report gross observation
29
247
1.19
0.34
1.6
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
6
45
1.34
0.34
1.0
1.6
—
10.0
—
0
12
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
74
1.36
0.33
1.3
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
59
643
0.89
0.29
3.4
3.0
mg/l
1073.1
354.6
0.30
38
405
(3020891) Body temperature
9
76
1.19
0.25
15.3
4.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
9
77
1.17
0.24
10.1
3.5
mmol/l
3.8
4.0
—
9
65
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
46
503
0.90
0.24
1.5
1.6
mmol/l
1.4
1.3
0.29
39
388
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
25
285
0.86
0.24
4.5
4.5
%
33.6
32.8
0.14
16
166
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
41
1.22
0.22
1.8
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
42
1.19
0.21
1.4
2.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
5
42
1.19
0.21
1.8
1.2
—
2.1
—
0
5
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
1.8
—
0
5
(3038026) Centromere Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
52
1.16
0.19
1.0
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
7
58
1.21
0.18
2.0
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
5
70
0.71
0.17
1.2
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
9
82
1.10
0.15
1.2
1.3
u/ml
157.1
200.6
—
9
71
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
15
167
0.89
0.11
1.8
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
23
213
1.09
0.09
1.3
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
66
652
1.02
0.01
3.0
3.0
mmol/l
6.2
7.0
0.61
54
530
(3003327) Ova and parasites identified in Stool by Light microscopy
5
54
0.92
0.00
2.4
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
7
70
1.00
0.00
2.0
1.9
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
15
150
1.00
0.00
8.7
4.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4094501)
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4034850)
5
59
0.84
0.00
55.4
9.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
6
68
0.88
0.00
3.0
3.7
mg/l
39.0
25.9
—
6
42
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4015189)
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.0
—
15.9
—
0
7
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002224) Polysomnography panel
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
50
1.00
0.00
1.4
1.4
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
6
0.00
0.00
0.0
1.3
—
6.6
—
0
6

Mortality – FinRegistry

↥

Association

Association between endpoint M13_VERTEBCOLLAPSE and mortality.

Females

Parameter HR [95% CI] p-value
M13_VERTEBCOLLAPSE 1.885 [1.61, 2.21] < 0.001
Birth year 0.996 [0.99, 1.0] 0.355

During the follow-up period (1.1.1998 — 31.12.2019), 934 out of 1714 females with M13_VERTEBCOLLAPSE died.

Males

Parameter HR [95% CI] p-value
M13_VERTEBCOLLAPSE 2.57 [1.93, 3.42] < 0.001
Birth year 0.987 [0.98, 1.0] 0.008

During the follow-up period (1.1.1998 — 31.12.2019), 507 out of 886 males with M13_VERTEBCOLLAPSE died.

Mortality risk

Mortality risk for people of age

years, who have M13_VERTEBCOLLAPSE.

N-year risk Females Males
1 0.216% 0.475%
5 1.281% 3.061%
10 3.045% 7.447%
15 5.762% 13.539%
20 9.692% 22.336%

Relationships between endpoints

↥

Index endpoint: M13_VERTEBCOLLAPSE – Collapsed vertebra, not elsewhere classified

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data